Mirum Pharmaceuticals (MIRM) EBIT Growth (1y) (2020 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 12.69% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 75.16% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -347.04% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 80.62% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 1.27% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 8.65% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 1,386.07% |
| 10 | Mirum Pharmaceuticals | 5.97 Bn | 5.59 Bn | 131.08 Mn | -5,099.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -5,099.66% |
| Dec 31, 2025 | 81.15% |
| Sep 30, 2025 | 120.52% |
| Jun 30, 2025 | 79.41% |
| Mar 31, 2025 | 42.64% |
| Dec 31, 2024 | 25.67% |
| Sep 30, 2024 | 49.56% |
| Jun 30, 2024 | 0.17% |
| Mar 31, 2024 | 2.50% |
| Dec 31, 2023 | 4.61% |
| Sep 30, 2023 | 23.52% |
| Jun 30, 2023 | 22.80% |
| Mar 31, 2023 | 17.07% |
| Dec 31, 2022 | 25.04% |
| Sep 30, 2022 | 23.22% |
| Jun 30, 2022 | 15.94% |
| Mar 31, 2022 | 31.25% |
| Dec 31, 2021 | -23.34% |
| Sep 30, 2021 | -97.20% |
| Jun 30, 2021 | -58.50% |
| Mar 31, 2021 | -116.11% |
| Dec 31, 2020 | -98.04% |
| Sep 30, 2020 | -36.86% |
| Jun 30, 2020 | -68.14% |
| Mar 31, 2020 | -256.27% |